Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 17 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Solid Tumor 3 Pain, Postoperative 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Gastrointestinal Stromal Tumors 3 Colorectal Neoplasms 3 Anxiety Disorders 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Pain 2 Glioma 2 Colonic Neoplasms 2 Choledocholithiasis 2 Choledochal Cyst 2 Carcinoma 2 Advanced Solid Tumor 2 Advanced Malignancies 2 cMET-dysregulated Advanced Solid Tumors 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Morphine 8 Analgesics, Opioid 8 Acetaminophen 8 Fentanyl 7 Dexmedetomidine 7 Lidocaine 6 Anesthesia, General 6 Saline Solution 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Therapeutics 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Midazolam × Clear all

NCT04597268 2023-01-10

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

National Cancer Institute, Egypt

Phase NA Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡